Bernstein CN, Fried M, Krabshuis JH, Cohen H, Eliakim R, Fedail S, Gearry R, Goh KL, Hamid S, Khan AG, LeMair AW, Malfertheiner , Ouyang Q, Rey JF, Sood A, Steinwurz F, Thomsen OO, Thomson A, Watermeyer G: World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. Inflamm Bowel Dis. 2010, 16 (1): 112-124. 10.1002/ibd.21048.
Article
PubMed
Google Scholar
Quigley EM, Abdel-Hamid H, Barbara G, Bhatia SJ, Boeckxstaens G, De Giorgio R, Delvaux M, Drossman DA, Foxx-Orenstein AE, Guarner F, Gwee KA, Harris LA, Hungin AP, Hunt RH, Kellow JE, Khalif IL, Kruis W, Lindberg G, Olano C, Moraes-Filho JP, Schiller LR, Schmulson M, Simren M, Tzeuton C: A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome. J Clin Gastroenterol. 2012, 46 (5): 356-366. 10.1097/MCG.0b013e318247157c.
Article
PubMed
Google Scholar
Schroder O, Naumann M, Shastri Y, Povse N, Stein J: Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin. Aliment Pharmacol Ther. 2007, 26 (7): 1035-1042. 10.1111/j.1365-2036.2007.03457.x.
Article
CAS
PubMed
Google Scholar
Langhorst J, Elsenbruch S, Mueller T, Rueffer A, Spahn G, Michalsen A, Dobos GJ: Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis. Inflamm Bowel Dis. 2005, 11 (12): 1085-1091. 10.1097/01.MIB.0000187980.08686.18.
Article
PubMed
Google Scholar
Poullis A, Foster R, Northfield TC, Mendall MA: Review article: faecal markers in the assessment of activity in inflammatory bowel disease. Aliment Pharmacol Ther. 2002, 16 (4): 675-681. 10.1046/j.1365-2036.2002.01196.x.
Article
CAS
PubMed
Google Scholar
Roseth AG, Schmidt PN, Fagerhol MK: Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999, 34 (1): 50-54. 10.1080/00365529950172835.
Article
CAS
PubMed
Google Scholar
Brock JH: Lactoferrin--50 years on. Biochem Cell Biol. 2012, 90 (3): 245-251. 10.1139/o2012-018.
Article
CAS
PubMed
Google Scholar
Kopylov U, Rosenfeld G, Bressler B, Seidman E: Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease. Inflamm Bowel Dis. 2014, 20 (4): 742-756. 10.1097/01.MIB.0000442681.85545.31.
Article
PubMed
Google Scholar
Guerrant RL, Araujo V, Soares E, Kotloff K, Lima AA, Cooper WH, Lee AG: Measurement of fecal lactoferrin as a marker of fecal leukocytes. J Clin Microbiol. 1992, 30 (5): 1238-1242.
CAS
PubMed
PubMed Central
Google Scholar
Walker TR, Land ML, Kartashov A, Saslowsky TM, Lyerly DM, Boone JH, Rufo PA: Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007, 44 (4): 414-422. 10.1097/MPG.0b013e3180308d8e.
Article
CAS
PubMed
Google Scholar
Schoepfer AM, Trummler M, Seeholzer P, Seibold-Schmid B, Seibold F: Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflamm Bowel Dis. 2008, 14 (1): 32-39. 10.1002/ibd.20275.
Article
PubMed
Google Scholar
Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ: Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol. 2008, 103 (1): 162-169. 10.1111/j.1572-0241.2007.01556.x.
Article
PubMed
Google Scholar
Kane SV, Sandborn WJ, Rufo PA, Zholudev A, Boone J, Lyerly D, Camilleri M, Hanauer SB: Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation. Am J Gastroenterol. 2003, 98 (6): 1309-1314. 10.1111/j.1572-0241.2003.07458.x.
Article
CAS
PubMed
Google Scholar
Sidhu R, Wilson P, Wright A, Yau CW, D'Cruz FA, Foye L, Morley S, Lobo AJ, McAlindon ME, Sanders DS: Faecal lactoferrin–a novel test to differentiate between the irritable and inflamed bowel?. Aliment Pharmacol Ther. 2010, 31 (12): 1365-1370. 10.1111/j.1365-2036.2010.04306.x.
Article
CAS
PubMed
Google Scholar
Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, Moons KG, de Wit NJ: Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med. 2008, 46 (9): 1275-1280.
Article
CAS
PubMed
Google Scholar
Joishy M, Davies I, Ahmed M, Wassel J, Davies K, Sayers A, Jenkins H: Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009, 48 (1): 48-54. 10.1097/MPG.0b013e31816533d3.
Article
CAS
PubMed
Google Scholar
Silberer H, Kuppers B, Mickisch O, Baniewicz W, Drescher M, Traber L, Kempf A, Schmidt-Gayk H: Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome. Clin Lab. 2005, 51 (3–4): 117-126.
CAS
PubMed
Google Scholar
Dai J, Liu WZ, Zhao YP, Hu YB, Ge ZZ: Relationship between fecal lactoferrin and inflammatory bowel disease. Scand J Gastroenterol. 2007, 42 (12): 1440-1444. 10.1080/00365520701427094.
Article
CAS
PubMed
Google Scholar
Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J: Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol. 2006, 6: 9-10.1186/1471-2288-6-9.
Article
PubMed
PubMed Central
Google Scholar
Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM: Systematic reviews of diagnostic test accuracy. Ann Intern Med. 2008, 149 (12): 889-897. 10.7326/0003-4819-149-12-200812160-00008.
Article
PubMed
PubMed Central
Google Scholar
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ. 2003, 327 (7414): 557-560. 10.1136/bmj.327.7414.557.
Article
PubMed
PubMed Central
Google Scholar
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7 (3): 177-188. 10.1016/0197-2456(86)90046-2.
Article
CAS
PubMed
Google Scholar
Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315 (7109): 629-634. 10.1136/bmj.315.7109.629.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gisbert JP, McNicholl AG, Gomollon F: Questions and answers on the role of fecal lactoferrin as a biological marker in inflammatory bowel disease. Inflamm Bowel Dis. 2009, 15 (11): 1746-1754. 10.1002/ibd.20920.
Article
PubMed
Google Scholar
Lundberg JO, Hellstrom PM, Fagerhol MK, Weitzberg E, Roseth AG: Technology insight: calprotectin, lactoferrin and nitric oxide as novel markers of inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol. 2005, 2 (2): 96-102. 10.1038/ncpgasthep0094.
Article
CAS
PubMed
Google Scholar
Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Farkkila M: Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis. 2008, 14 (1): 40-46. 10.1002/ibd.20312.
Article
PubMed
Google Scholar
Jones J, Loftus EV, Panaccione R, Chen LS, Peterson S, McConnell J, Baudhuin L, Hanson K, Feagan BG, Harmsen SW, Zinsmeister AR, Helou E, Sandborn WJ: Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease. Clin Gastroenterol Hepatol. 2008, 6 (11): 1218-1224. 10.1016/j.cgh.2008.06.010.
Article
PubMed
Google Scholar
Xiang JY, Ouyang Q, Li GD: [Significance of fecal lactoferrin in evaluation of disease activity in ulcerative colitis]. Zhonghua Yi Xue Za Zhi. 2007, 87 (32): 2262-2264.
CAS
PubMed
Google Scholar
D'Inca R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, Martines D, Sturniolo GC: Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease. Int J Colorectal Dis. 2007, 22 (4): 429-437. 10.1007/s00384-006-0159-9.
Article
PubMed
Google Scholar
Buderus S, Boone J, Lyerly D, Lentze MJ: Fecal lactoferrin: a new parameter to monitor infliximab therapy. Dig Dis Sci. 2004, 49 (6): 1036-1039.
Article
CAS
PubMed
Google Scholar
Sipponen T, Savilahti E, Karkkainen P, Kolho KL, Nuutinen H, Turunen U, Farkkila M: Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohn's disease. Inflamm Bowel Dis. 2008, 14 (10): 1392-1398. 10.1002/ibd.20490.
Article
PubMed
Google Scholar
Sutherland AD, Gearry RB, Frizelle FA: Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum. 2008, 51 (8): 1283-1291. 10.1007/s10350-008-9310-8.
Article
PubMed
Google Scholar
Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F: Accuracy of four fecal assays in the diagnosis of colitis. Dis Colon Rectum. 2007, 50 (10): 1697-1706. 10.1007/s10350-007-0303-9.
Article
PubMed
Google Scholar
Burri E, Manz M, Rothen C, Rossi L, Beglinger C, Lehmann FS: Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort. Clin Chim Acta. 2013, 416: 41-47.
Article
CAS
PubMed
Google Scholar
Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM: The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003, 56 (11): 1129-1135. 10.1016/S0895-4356(03)00177-X.
Article
PubMed
Google Scholar
McGee S: Simplifying likelihood ratios. J Gen Intern Med. 2002, 17 (8): 646-649.
Article
PubMed
Google Scholar
Deeks JJ: Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ. 2001, 323 (7305): 157-162.
Article
CAS
PubMed
PubMed Central
Google Scholar
Joshi S, Lewis SJ, Creanor S, Ayling RM: Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers. Ann Clin Biochem. 2010, 47 (Pt 3): 259-263.
Article
CAS
PubMed
Google Scholar
Sugi K, Saitoh O, Hirata I, Katsu K: Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol. 1996, 91 (5): 927-934.
CAS
PubMed
Google Scholar